# A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

> **NCT01709331** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 18 (actual)

## Conditions studied

- Hypogonadism
- Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** Corifollitropin alfa
- **DRUG:** hCG

## Key facts

- **NCT ID:** NCT01709331
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-11
- **Primary completion:** 2015-04-08
- **Final completion:** 2015-04-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709331, "A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01709331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*